Last reviewed · How we verify
NCT04287569: ENDOSPECTRALE
Multispectral Imaging Endoscopy in Digestive Inflammation
NA trial testing Record during endoscopy of video-endoscopy sequences and reflectance in Digestive Inflammation in 102 participants. Completed in 22 December 2021.
22 December 2021
Quick facts
| Lead sponsor | Assistance Publique - Hôpitaux de Paris |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 102 |
| Start date | 2 September 2020 |
| Primary completion | 22 December 2021 |
| Estimated completion | 22 December 2021 |
| Sites | 1 location across France |
Drugs / interventions tested
- Record during endoscopy of video-endoscopy sequences and reflectance
Conditions studied
- Digestive Inflammation — all drugs for Digestive Inflammation →
Sponsor
Assistance Publique - Hôpitaux de Paris — full company profile →
Who can join
18 and older, any sex, with Digestive Inflammation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study aims as principal objective to show the association between reflectance intensity of mucosa at different wave lengths and * the presence of acute or chronic inflammation in stomach or rectum and normal mucosa; * the presence of glandular atrophy in stomach or intestinal metaplasia. The secondary objectives are: * to identify reflectance profile which characterize an acute or a chronic inflammation, a glandular atrophy or an intestinal metaplasia, respectively; * to find a correlation between the reflectance to different frequencies and intensity of inflammation according to Sydney Classification in stomach (Dixon M F 1994) and in rectum (Erben U 2014).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Multimodal imaging as optical biopsy system for gastritis diagnosis in humans, and input of the mouse model.
Bazin T, Krebs A, Jobart-Malfait A, Camilo V, et al · · 2021 · cited 2× · PMID 34229278 · DOI 10.1016/j.ebiom.2021.103462
Verify or expand the search:
- PubMed search for NCT04287569
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Assistance Publique - Hôpitaux de Paris trials
Trials by the same sponsor.
- NCT07443436 — Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants · Phase 2 · not yet recruiting
- NCT07499492 — Red Blood Cell Transfusion to Optimize Extubation · NA · not yet recruiting
- NCT07379918 — Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer · recruiting
- NCT07473869 — Smartphone Application for Automated Measurement of Capillary Refill Time (CRT) · not yet recruiting
- NCT07505394 — Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04287569 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assistance Publique - Hôpitaux de Paris
- Last refreshed: 28 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04287569.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing